Escolha sua fonte:
 Arimo
 Merriweather
 Mukta Malar
 Open Sans Condensed
 Rokkitt
 Source Sans Pro
 Login


 Português 
 Français 
 English 
 Español 

[Valid RSS] RSS
bar

Banco de dados - (CIANE)

Descrição deste banco de dados documental (Site da CIANE)
Atualmente 3111 fichas
Canal do YouTube (tutorial)

https://ciane.net/id=2303

Criado em : 03 Jan 2009
Alterado em : 03 Jan 2009

 Modificar esta ficha
Siga este link somente se você tiver um palavra chave de editor!


Compartilhar: Facebook logo   Tweeter logo   Difícil

Nota bibliográfica (sem autor) :

Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection. Cochrane Database Syst Rev. 2007 Jan 24;(1):CD003510.Click here to read

Autores :

Volmink J, Siegfried NL, van der Merwe L, Brocklehurst P.

Ano de publicação :

2007

URL(s) :

http://mrw.interscience.wiley.com/cochrane/clsysre…

Résumé (français)  :

Abstract (English)  :

BACKGROUND: Antiretroviral drugs (ARV) reduce viral replication and can reduce mother-to-child transmission of HIV either by lowing plasma viral load in pregnant women or through post-exposure prophylaxis in their newborns. In rich countries, highly active antiretroviral therapy (HAART) has reduced the vertical transmission rates to around 1-2%, but HAART is not yet widely available in low and middle income countries. In these countries, various simpler and less costly antiretroviral regimens have been offered to pregnant women or to their newborn babies, or to both.

OBJECTIVES: To determine whether, and to what extent, antiretroviral regimens aimed at decreasing the risk of mother-to-child transmission of HIV infection achieve a clinically useful decrease in transmission risk, and what effect these interventions have on maternal and infant mortality and morbidity.

SEARCH STRATEGY: We sought to identify all relevant studies regardless of language or publication status by searching the Cochrane HIV/AIDS Review Group Trials Register, The Cochrane Library, Medline, EMBASE and AIDSearch and relevant conference abstracts. We also contacted research organizations and experts in the field for unpublished and ongoing studies. The original review search strategy was updated in 2006.

SELECTION CRITERIA: Randomised controlled trials of any antiretroviral regimen aimed at decreasing the risk of mother-to-child transmission of HIV infection compared with placebo or no treatment.

DATA COLLECTION AND ANALYSIS: Two authors independently selected relevant studies, extracted data and assessed trial quality. For the primary outcomes, we used survival analysis to estimate the probability of infants being infected with HIV (the observed proportion) at various specific time-points and calculated efficacy at a specific time as the relative reduction in the proportion infected. Efficacy, at a specific time, is defined as the preventive fraction in the exposed group compared to the reference group, which is the relative reduction in the proportion infected: 1-(Re/Rf). For those studies where efficacy and hence confidence intervals were not calculated, we calculated the approximate confidence intervals for the efficacy using recommended methods. For analysis of results that are not based on survival analyses we present the relative risk for each trial outcome based on the number randomised. No meta-analysis was conducted as no trial assessed the identical drug regimens.

MAIN RESULTS: Eighteen trials including 14,398 participants conducted in 16 countries were eligible for inclusion in the review.

[…]

AUTHORS’ CONCLUSION: Short courses of antiretroviral drugs are effective for reducing mother-to-child transmission of HIV and are not associated with any safety concerns in the short-term. A combination of ZDV and 3TC given to mothers in the antenatal, intrapartum and postpartum periods and to babies for a week after delivery or a single dose of NVP given to mothers in labour and babies immediately after birth may be most effective. Where HIV infected women present late for delivery, post-exposure prophylaxis with a single dose of NVP immediately after birth plus ZDV for the first 6 weeks of life is beneficial. The long term implications of the emergence of resistant mutations following the use of these regimens require further study.

Sumário (português)  :

Resumen (español)  :

Comentários :

Argument (français) :

Argument (English):

Researchers theorized that a course of antiretroviral drugs (ARV) given to pregnant women and their newborn babies could reduce the risk of mother-to-child transmission.

Argumento (português):

Argumento (español):

Palavras-chaves :

➡ VIH

Autor da esta ficha :

Bernard Bel — 03 Jan 2009

Discussão (exibir apenas português)
 
➡ Reservado para usuários identificados



 Li a carta de discussões e aceito as condições
[Ocultar diretrizes]

➡ Diretrizes de discussão

1) Os comentários são destinados a esclarecer o conteúdo do artigo ou fornecer links para aprofundar o assunto
2) Os comentários são públicos e as opiniões expressas são de responsabilidade dos autores
3) Evite anedotas e histórias pessoais
4) Quaisquer comentários fora do tópico ou que contenham comentários inaceitáveis serão excluídos sem aviso prévio

barre

Efectuar uma nova consulta especialista --- Outro pedido simples

Criação de uma ficha --- Importar registros

Gerenciamento de usuários --- Fazer backup do banco de dados --- Contato

bar

Esta base de dados criada pela Alliance francophone pour l'accouchement respecté (AFAR) é gerida
pela Collectif interassociatif autour de la naissance (CIANE, https://ciane.net).
Ele é alimentado pelas contribuições de voluntários interessados ​​em compartilhar informações científicas.
Se você aprovar este projeto, você pode nos ajudar de várias maneiras:
(1) tornar-se um colaborador com base nisso, se você tem um pouco experiência na literatura científica
(2) ou apoio financeiro CIANE (veja abaixo)
(3) ou tornar-se um membro da outra associação afiliada à CIANE.
Faça login ou crie uma conta para seguir as alterações ou se tornar um editor.
Contato bibli(arobase)ciane.net para mais informações.

Valid CSS! Valid HTML!
Doar para a CIANE (clique em “Faire un don”) nos ajudará a manter e desenvolver sites e bancos de dados
públicos para o apoio das decisões informadas dos pais e cuidadores com relação ao parto